Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormonal contraception can improve acne and excess hair growth, enhancing women's quality of life.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Sex hormones influence immune responses and may help treat diseases.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Ovarian hyperthecosis can cause high testosterone and symptoms like hair loss, and surgery can help improve these symptoms.

A man with severe hair loss regrew hair after hormone treatment.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Phytochemicals from plants may help improve hormonal health naturally.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

PCOS treatment should be personalized based on individual symptoms and health goals.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Leydig cell tumors can cause high testosterone in women and are treated by removing the ovaries.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.